Vascular and cardiac functional and structural screening to identify risk of future morbid events: Preliminary observations

Journal of the American Society of Hypertension

Volumn 5, Issue 5, 2011, Pages 401-409

  Duprez, Daniel A ^a   Florea, Natalia ^a   Zhong, Wei ^b   Grandits, Gregory A ^b   Hawthorne, Caitlin K ^b   Hoke, Lynn ^a   Cohn, Jay N ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Atherosclerosis; blood pressure; cholesterol; early detection

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; ANGINA PECTORIS; ARTICLE; ASYMPTOMATIC DISEASE; BLOOD PRESSURE; FEMALE; FRAMINGHAM RISK SCORE; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; STROKE; STRUCTURED QUESTIONNAIRE;

AGED; ALGORITHMS; CARDIOVASCULAR DISEASES; COMORBIDITY; CORONARY DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; LIPOPROTEINS, LDL; MALE; MASS SCREENING; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 80052961405     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2011.05.001     Document Type: Article

References (25)

1. J.A. Staessen, J.G. Wang, and L. Thijs Cardiovascular protection and blood pressure reduction: a meta-analysis Lancet 358 2001 1305 1315 (Pubitemid 33016494)
2. F. Turnbull Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials Lancet 362 2003 1527 1535 (Pubitemid 37410190)
3. Prospective Studies Collaboration S. Lewington, G. Whitlock, R. Clarke, P. Sherliker, J. Emberson, and J. Halsey Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths Lancet 370 2007 1829 1839
4. C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, and C. Pollicino Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
5. P.M. Rothwell, A.J. Coull, M.F. Giles, S.C. Howard, L.E. Silver, L.M. Bull Oxford Vascular Study Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study) Lancet 363 2004 1925 1933 (Pubitemid 38759651)
6. J.N. Cohn, and D.A. Duprez Time to foster a rational approach to preventing cardiovascular morbid events J Am Coll Cardiol 52 2008 327 329 (Pubitemid 352001345)
7. P. Greenland, and D. Lloyd-Jones Defining a rational approach to screening for cardiovascular risk in asymptomatic patients J Am Coll Cardiol 52 2008 330 332 (Pubitemid 352005812)
8. S.C. Smith Jr., S.N. Blair, R.O. Bonow, L.M. Brass, M.D. Cerqueira, and K. Dracup AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology J Am Coll Cardiol 38 2001 1581 1583 (Pubitemid 33033046)
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
10. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572 (Pubitemid 37430158)
11. Authors/Task Force Members: Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al.; ESC Committee for Practice Guidelines (CPG): Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, et al.; ESH Scientific Council: Kjeldsen SE, Erdine S, Narkiewicz K, Kiowski W, Agabiti-Rosei E, Ambrosioni E, et al.; Document reviewers: Filippatos G, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-536.
12. D.M. Lloyd-Jones, P.W.F. Wilson, M.G. Larson, A. Beiser, E.P. Leip, and R.B. D'Agostino Framingham risk score and prediction of lifetime risk for coronary heart disease Am J Cardiol 94 2004 20 24 (Pubitemid 38813447)
13. K. Kotseva, D. Wood, G. De Backer, D. De Bacquer, K. Pyörä lä, U. Keil EUROASPIRE Study Group Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries Lancet 373 2009 929 940
14. N.J. Stone, S. Bilek, and S. Rosenbaum Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options Am J Cardiol 96 4A 2005 53E 59E (Pubitemid 41140371)
15. D.A. Duprez, and J.N. Cohn Arterial stiffness as a risk factor for coronary atherosclerosis Curr Atheroscler Rep 9 2007 139 144 (Pubitemid 47376985)
16. R. Mundal, S.E. Kjedsen, L. Sandvik, G. Eriksen, E. Thaulow, and J. Erikssen Exercise blood pressure predicts cardiovascular mortality in middle-aged men Hypertension 24 1994 56 62 (Pubitemid 24195404)
17. M.W. Lorenz, H.S. Markus, M.L. Bots, M. Rosvall, and M. Sitzer Prediction of clinical cardiovascular events with carotid intima-media thickness. A systematic review and meta-analyses Circulation 115 2007 459 467 (Pubitemid 46184197)
18. K. McGeechan, G. Liew, P. Macaskill, L. Irwig, R. Klein, and A.R. Sharrett Risk prediction of coronary heart disease based on retinal vascular caliber (from the Atherosclerosis Risk In Communities [ARIC] Study) Am J Cardiol 102 2008 58 63
19. R.J. MacIsaac, G. Jerums, and M.E. Cooper New insights into the significance of microalbuminuria Curr Opin Nephrol Hypertens 13 2004 83 91 (Pubitemid 39069903)
20. L.C. Costello-Boerrigter, and J.C. Burnett Jr. The prognostic value of N-terminal proB-type natriuretic peptide Nat Clin Pract Cardiovasc Med 2 2005 194 201 (Pubitemid 40812482)
21. J.N. Cohn, L. Hoke, W. Whitwam, P.A. Sommers, A.L. Taylor, and D. Duprez Screening for early detection of cardiovascular disease in asymptomatic individuals Am Heart J 146 2003 679 685 (Pubitemid 37281714)
22. D.A. Duprez, and J.N. Cohn Identifying early cardiovascular disease to target candidates for treatment J Clin Hypertens 10 2008 226 231
23. S. Sheridan, M. Pignone, and C. Mulrow Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians J Gen Intern Med 18 2003 1039 1052 (Pubitemid 38091400)
24. R.B. D'Agostino Sr., R.S. Vasan, M.J. Pencina, P.A. Wolf, M. Cobain, and J.M. Massaro General cardiovascular risk profile for use in primary care: The Framingham Heart Study Circulation 117 2008 743 753 (Pubitemid 351640675)
25. D.A. Duprez, N.D. Florea, K. Jones, and J.N. Cohn Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities: the DETECTIV Pilot Study J Am Coll Cardiol 50 2007 835 839 (Pubitemid 47268740)